Related Experiment Video
Updated: Jan 12, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Management of Infants Treated for Respiratory Viral Infections: A Finnish Retrospective Register-Based Study
Sallamaria Länsisalo1, Paula Heikkilä2,3, Sauli Palmu2,4
1Faculty of Medicine and Health Technology Tampere University Tampere Finland.
Background And Aims:
Viral respiratory tract infections are common in all age groups, and they are responsible for a vast number of health care visits every year. Furthermore, the incidence of respiratory infections is the highest in children. We aimed to determine how infants presenting with fever and symptoms of respiratory infections were treated at Tampere University Hospital (Tays) and their responses to treatment. The secondary purpose was to describe the specific diagnosis behind the respiratory symptoms.
Methods:
This study was conducted in the Department of Paediatrics in Tays, Finland. Inclusion criteria were age < 1 year, fever, and symptoms of a respiratory infection. We documented from the electronic patient records the medication and other treatments the infants received during their hospital stays. For infants given the same medication multiple times, only the first dosing and response to that medication were documented.
Results:
The study included 119 episodes (117 infants), 50 (42%) of whom were hospitalized. Symptom-relieving medications, such as paracetamol, were used frequently, with generally good responses. Overall, 59% of the infants were administered antibiotics, the most common indication being otitis media. The most common primary or secondary diagnosis was bronchiolitis or bronchitis (43%).
Conclusion:
Nearly half of the infants needed hospitalization. Symptom-relieving medications, such as analgesics, were a key treatment choice, and the responses were generally good. Although the majority of the infants had a viral infection, antibiotics were used frequently, at least partially due to secondary bacterial infections.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...

